GNS Genus plc
2126.00GBp-0.84%Mkt Cap: 1.53B $P/E: 5.001d ago
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Gen…
Industry Peers
Biotechnology$127.54BUSDP/E 29.3
$81.13BUSD
$74.79BUSDP/E 18.0
$57.11BUSDP/E 34.8
$55.24BUSDP/E 36.1
$44.51BUSD
$41.63BUSDP/E 17.7
$41.14BUSDP/E 64.7
$32.74BUSDP/E 30.1
$29.42BUSDP/E 37.1
$25.84BUSD
$24.53BUSD
$24.01BUSDP/E 30.3
$23.13BUSDP/E 14.5
$22.67BUSD
$21.61BUSDP/E 29.3
$15.32BUSDP/E 16.2
$15.01BUSDP/E 17.5
$14.58BUSDP/E 18.6
$13.78BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
SSimply Wall Street | ||
 Genus H2 Earnings Call Highlights Genus (LON:GNS) reported higher adjusted profit and cash generation for FY 2026, supported by growth in its porcine genetics business, efficiency gains in bovine genetics and contributions from joint ventures. The company also announced a £60 million share buyback and proposed a 10% increase in its | ||
AAskTraders | ||